Table 1.
Baseline clinical and demographic characteristics.
| Colchicine (n = 81) | Placebo (n = 71) | P | |
|---|---|---|---|
| Age (years) | 59.0 ± 15.2 | 59.8 ± 13.1 | 0.730 |
| Women (%) | 28.4 | 18.3 | 0.204 |
| BMI (kg/m2) | 29.3 ± 5.4 | 29.3 ± 5.6 | 1.00 |
| Creatinine (mg/dL) | 0.9 ± 0.3 | 0.9 ± 0.3 | 1.00 |
| eGFR (mL/minute/1.73 m2) | 101.4 ± 38.8 | 98.5 ± 34.6 | 0.629 |
| Heart rate (beats/minute) | 74.7 ± 13.9 | 72.5 ± 11.8 | 0.298 |
| Hypertension (%) | 55.6 | 62.0 | 0.526 |
| Diabetes mellitus (%) | 39.5 | 49.3 | 0.293 |
| Hypercholesterolemia (%) | 54.3 | 66.2 | 0.184 |
| Active smoking (%) | 29.6 | 19.7 | 0.223 |
| Prior MI (%) | 18.5 | 26.8 | 0.303 |
| LVEF (%) | 56.8 ± 10.9 | 56.6 ± 10.5 | 0.909 |
BMI = body mass index, eGFR = estimated glomerular filtration rate, MI = myocardial infarction, LVEF = left ventricular ejection fraction.